GMP Training at LBE Pharma: Opening the Door to Pharmaceutical Quality Assurance in 2025

LBE Pharma, as an international pharmaceutical manufacturing enterprise with a global presence, has been deeply rooted in the domestic market while actively expanding its international business. Recently, the company invited a senior GMP consultant to provide guidance. The company's management, production team, and quality management team engaged in comprehensive and in-depth discussions with the consultant.'

With over 20 years of GMP auditing experience, the consultant possesses a profound understanding of domestic and international GMP principles and requirements. During the exchange, the consultant shared unique insights on facility layout and construction, quality system establishment and operation, key considerations for drug-device combination products (autoinjectors), and registration strategy planning and implementation. A series of highly valuable recommendations were provided to help the company optimize its management system across multiple dimensions, effectively enhancing its competitiveness in the global market.

In the training session, the consultant emphasized the critical responsibilities and operational key points of each role in GMP implementation, tailored to different job functions. This provided employees with clearer work direction and improved methodologies. Through this training, frontline production staff gained a more precise understanding of production process regulations and standard operating procedures (SOPs), enabling more effective monitoring and documentation of production processes. Quality control personnel deepened their grasp of laboratory management requirements and operational standards for various testing items, contributing to improved accuracy and reliability of test data. Equipment maintenance personnel further familiarized themselves with standard procedures for equipment validation, calibration, and maintenance, ensuring optimal operational conditions and providing solid support for pharmaceutical production.

This exchange activity allowed the company’s team to gain in-depth knowledge of international GMP concepts, significantly enhancing the robustness and sophistication of the company’s quality system. It laid a solid foundation for the steady advancement of the company’s globalization strategy. Moving forward, Fuzhou LBE Pharma will continue to uphold an open and learning-oriented attitude, actively collaborating with industry experts to further strengthen its capabilities and contribute to the global pharmaceutical and healthcare industry.